Dow Up 0.59% Nasdaq Up 0.75%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
355.47 9.44(2.73%) Sep 16, 4:00PM EDT
Prev Close:346.03
Open:346.82
Bid:255.00 x 100
Ask:373.70 x 100
1y Target Est:366.11
Beta:0.65
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:345.00 - 356.21
52wk Range:257.69 - 369.31
Volume:821,443
Avg Vol (3m):850,064
Market Cap:35.69B
P/E (ttm):101.91
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
REGNUp 2.73%35.69B
AMGN105.84B
NVS228.99B
RHHBY254.67B

Key Statistics

Forward P/E (1 yr):28.85
P/S (ttm):13.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.11
Quarterly EPS Est (Sep-14) :2.57
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback